National Center for Tumor Diseases (NCT) Heidelberg
Paula Hoffmeister-Wittmann is a highly skilled medical professional currently serving as a Resident Doctor and NCT Clinician Scientist Fellow at the National Center for Tumor Diseases (NCT) Heidelberg since May 2022. This position focuses on overcoming chemoresistance and radioresistance in cholangiocarcinoma, evaluating various in vivo models, establishing organoid cultures, and analyzing molecular differences in cholangiocarcinoma subtypes. In addition to this role, Paula has been a Resident Doctor for RadioOncology & Radiation Therapy at Universitätsklinikum Heidelberg from January 2022 to March 2024, concentrating on liver cancer clinical studies. Prior experience includes a Doctoral Student position at NCT Heidelberg where Paula researched the antiapoptotic Bcl-2 protein family in the context of cholangiocarcinoma. Training also encompasses practical years at various esteemed institutions in visceral surgery, hematology-oncology, gastroenterology, and radiology. Paula holds a Dr. med. degree from Heidelberg University and a Staatsexamen in medicine, supplemented by studies at Nantes Université.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.